Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks

作     者：Balwir Matharoo-Ball Mbayame Diop Zisis Kozlakidis 

作者机构：Director of BiobankG42 HealthcareAbu DhabiUnited Arab Emirates UniversitéCote d’AzurNice 06100France International Agency for Research on CancerWorld Health Organization69372 Lyon CEDEX 08France 

出 版 物：《Biosafety and Health》 (生物安全与健康（英文）)

年 卷 期：2022年第4卷第4期

页      面：280-282页

核心收录：

学科分类：12[管理学] 1204[管理学-公共管理] 120402[管理学-社会医学与卫生事业管理(可授管理学、医学学位)] 1004[医学-公共卫生与预防医学(可授医学、理学学位)] 10[医学] 

主　　题：Biobanks COVID-19 Biobank standards Biobank best practices Biobank networks 

摘      要：The coronavirus disease 2019(COVID-19)pandemic has highlighted the practice of infectious diseases biobanking,as well as existing challenges and ***,the future of infectious diseases biobanking in the post-pandemic era,shall not be an“entry-level versionof its counterpart in non-communicable diseases and large population cohorts,but incorporate the lessons *** constitute a critical research infrastructure supported by harmonized practices through the implementation of international standards,and perceived within the broader scope of healthcare s intersection with *** perspective paper considers the barriers in biobanking and standardization of practices,as well as the emerging opportunities in the field.